ReviewInternational urology and nephrology2025
Sodium-glucose co-transporter inhibitors for APOL1 kidney disease: A call for studies.
Baris Afsar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewInternational urology and nephrology2025
Baris Afsar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.